跳至主要内容
临床试验/NCT04494880
NCT04494880已完成早期 1 期

Marcaine Post-Operative Pain Study

State University of New York - Upstate Medical University1 个研究点 分布在 1 个国家目标入组 22 人开始时间: 2020年12月9日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
早期 1 期
状态
已完成
发起方
入组人数
22
试验地点
1
主要终点
Marcaine Use in Breast Reconstruction: Post-Operative Pain Scale Assessment per Breast

研究概览

简要总结

The study examines the efficacy of Marcaine in post-operative pain reduction for patients receiving breast reduction surgery. Patients who consent will be randomized to which breast receives a Marcaine injection and the other breast will have saline injected. Pain will be assessed one time post-operatively using a 1-10 pain scale.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
— 至 89 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Must be receiving bilateral breast reduction surgery

排除标准

  • Unilateral breast reduction surgery

研究组 & 干预措施

Treatment Group (Marcaine 1 Breast)

Experimental

Marcaine will be injected into one randomized breast and saline into the other in the treatment group.

干预措施: Bupivacaine Injection (Drug)

结局指标

主要结局

Marcaine Use in Breast Reconstruction: Post-Operative Pain Scale Assessment per Breast

时间窗: through study completion, an average of 1 year

Minimum score: 1 (minimal pain), Maximum score: 10 (worst pain possible/worst outcome), higher pain scores associated with worse outcomes

次要结局

未报告次要终点

研究者

发起方
State University of New York - Upstate Medical University
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验